XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 12,120,000 $ 11,609,000
Tax credit receivable 1,722,000 3,228,000
Prepaid expenses and other current assets 901,000 1,444,000
Total Current Assets 14,743,000 16,281,000
Non-Current Assets    
Property and equipment, net 258,000 270,000
Restricted cash 46,000 96,000
Right of use asset 1,077,000 1,272,000
In-process research and development 19,624,000 17,358,000
Deposits and other assets 82,000 75,000
Total Assets 35,830,000 35,352,000
Current Liabilities:    
Accounts payable 607,000 859,000
Accrued expenses 9,017,000 3,368,000
Accrued employee benefits 759,000 1,144,000
Deferred research and development tax credit-current portion 1,343,000 1,614,000
Loans payable-current 56,000 61,000
Operating lease liability-current portion 612,000 539,000
Total Current Liabilities 12,394,000 7,585,000
Non-current Liabilities    
Non-current contingent consideration 10,160,000 6,973,000
Loan Payable - non-current 1,639,000 92,000
Non-current deferred research and development tax credit 430,000 762,000
Non-current operating lease liability 584,000 873,000
Total Liabilities 25,207,000 16,285,000
Commitments and Contingencies (Note 13)
Stockholders' Equity:    
Preferred Stock; 10,000,000 authorized; none issued or outstanding at June 30, 2025 and December 31, 2024
Common stock, $0.001 par value; 350,000,000 shares authorized, 9,088,042 issued and 9,059,232 outstanding at June 30, 2025 and 2,811,259 issued and 2,782,449 outstanding at December 31, 2024 8,000 3,000
Additional paid-in capital 362,463,000 355,501,000
Treasury stock at cost, 28,809 shares at June 30, 2025 and at December 31, 2024 (288,000) (288,000)
Accumulated other comprehensive income (loss) 793,000 (1,178,000)
Accumulated deficit (352,353,000) (334,971,000)
Total Stockholders' Equity 10,623,000 19,067,000
Total Liabilities and Stockholders' Equity $ 35,830,000 $ 35,352,000